Concepedia

Xiaojia Li

XL

Statistics

Publications

3

Citations

229

H-Index

3

Active since

2010

Affiliations

Pfizer (United States)(Current)

Xiaojia Li is an author at Pfizer (United States) specializing in medicine, bone metabolism, and signal transduction.

Publications per year

2010–2024

3

Publications

3

Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease

Brian W. Strassle, Lilly Mark, Liza Leventhal et al. · Osteoarthritis and Cartilage · 2010 · 126 citations · Full text

, , +16

Serine Protease HTRA1 Antagonizes Transforming Growth Factor-β Signaling by Cleaving Its Receptors and Loss of HTRA1 In Vivo Enhances Bone Formation

Julie R. Graham, Angela Chamberland, Qingcong Lin et al. · PLoS ONE · 2013 · 71 citations · Full text

, , +10

A RANKL-UCHL1-sCD13 negative feedback loop limits osteoclastogenesis in subchondral bone to prevent osteoarthritis progression

Wenquan Liang, Xiaojia Li, Xingwei Duan et al. · Nature Communications · 2024 · 32 citations · Full text

, , +17

1–3 of 3